Kovack Advisors, Inc. Gilead Sciences, Inc. Call Options Transaction History

Kovack Advisors, Inc.

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $59 - $68	1 New	1 $0
Q4 2020 Jan 14, 2021	SELL	$56.65 - $64.55 $113 - $129	-2 Reduced 66.67%	1 $0
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $712 - $789	-10 Reduced 76.92%	3 $0
Q3 2017 Aug 02, 2018	BUY	$72.11 - $85.47 $721 - $854	10 Added 333.33%	13 $5,000
Q4 2016 Sep 10, 2018	BUY	N/A	3 New	3 $0
Q3 2016 Sep 25, 2018	SELL	N/A	-4 Closed	0 $0
Q1 2016 Oct 12, 2018	SELL	N/A	-5 Reduced 55.56%	4 $1,000
Q4 2015 Oct 18, 2018	BUY	N/A	1 Added 12.5%	9 $4,000
Q3 2015 Oct 29, 2018	SELL	N/A	-4 Reduced 33.33%	8 $4,000
Q2 2015 Nov 06, 2018	SELL	N/A	-4 Reduced 25.0%	12 $24,000
Q1 2015 Nov 13, 2018	SELL	N/A	-7 Reduced 30.43%	16 $17,000
Q4 2014 Nov 19, 2018	BUY	N/A	23	23 $27,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.